Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Exercise capacity in COPD patients with exercise-induced pulmonary hypertension.

Skjørten I, Hilde JM, Melsom MN, Hisdal J, Hansteen V, Steine K, Humerfelt S.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 31;13:3599-3610. doi: 10.2147/COPD.S161175. eCollection 2018.

2.

På tide med nye referanseverdier og grenseverdier for spirometri.

Langhammer A, Crowley S, Humerfelt S, Melbye H, Nag T, Svanes Ø.

Tidsskr Nor Laegeforen. 2018 Sep 3;138(13). doi: 10.4045/tidsskr.18.0345. Print 2018 Sep 4. Norwegian. No abstract available.

3.

Cardiopulmonary exercise test and PaO2 in evaluation of pulmonary hypertension in COPD.

Skjørten I, Hilde JM, Melsom MN, Hisdal J, Hansteen V, Steine K, Humerfelt S.

Int J Chron Obstruct Pulmon Dis. 2017 Dec 22;13:91-100. doi: 10.2147/COPD.S150034. eCollection 2018.

4.

Symptoms and quality of life in patients with chronic obstructive pulmonary disease treated with aclidinium in a real-life setting.

Lange P, Godtfredsen NS, Olejnicka B, Paradis BA, Curiac D, Humerfelt S, Telg G, Christensen HN, Bitsch MA, Andersen EW, Bjermer L.

Eur Clin Respir J. 2016 Jul 5;3:31232. doi: 10.3402/ecrj.v3.31232. eCollection 2016.

5.

Assessment of Right Ventricular Afterload in COPD.

Hilde JM, Skjørten I, Hansteen V, Melsom MN, Atar D, Hisdal J, Humerfelt S, Steine K.

COPD. 2016;13(2):176-85. doi: 10.3109/15412555.2015.1057275. Epub 2016 Feb 25.

PMID:
26914261
6.

Validity of the European short list of respiratory diseases: a 40-year autopsy study.

Gulsvik AK, Henriksen AH, Svendsen E, Humerfelt S, Gulsvik A.

Eur Respir J. 2015 Apr;45(4):953-61. doi: 10.1183/09031936.00085214. Epub 2014 Oct 30.

7.

Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

Wang Y, Stavem K, Dahl FA, Humerfelt S, Haugen T.

Int J Chron Obstruct Pulmon Dis. 2014 Jan 20;9:99-105. doi: 10.2147/COPD.S51467. eCollection 2014.

8.

Long-term improvements in pulmonary function 5 years after bariatric surgery.

Hewitt S, Humerfelt S, Søvik TT, Aasheim ET, Risstad H, Kristinsson J, Mala T.

Obes Surg. 2014 May;24(5):705-11. doi: 10.1007/s11695-013-1159-9.

PMID:
24435516
9.

Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension.

Hilde JM, Skjørten I, Grøtta OJ, Hansteen V, Melsom MN, Hisdal J, Humerfelt S, Steine K.

J Am Coll Cardiol. 2013 Sep 17;62(12):1103-1111. doi: 10.1016/j.jacc.2013.04.091. Epub 2013 Jul 10.

10.

Pulmonary artery pressure and PaO2 in chronic obstructive pulmonary disease.

Skjørten I, Hilde JM, Melsom MN, Hansteen V, Steine K, Humerfelt S.

Respir Med. 2013 Aug;107(8):1271-9. doi: 10.1016/j.rmed.2013.03.021. Epub 2013 Jun 12.

11.

Acetazolamide improves oxygenation in patients with respiratory failure and metabolic alkalosis.

Gulsvik R, Skjørten I, Undhjem K, Holø L, Frostad A, Saure EW, Lejlic V, Humerfelt S, Hansen G, Bruun Wyller T.

Clin Respir J. 2013 Oct;7(4):390-6. doi: 10.1111/crj.12025. Epub 2013 Jul 4.

PMID:
23578004
12.

Readmissions for COPD: propensity case-matched comparison between pulmonary and non-pulmonary departments.

Wang Y, Stavem K, Humerfelt S, Dahl FA, Haugen T.

Clin Respir J. 2013 Oct;7(4):375-81. doi: 10.1111/crj.12018. Epub 2013 Mar 20.

PMID:
23347439
13.

Haemodynamic responses to exercise in patients with COPD.

Hilde JM, Skjørten I, Hansteen V, Melsom MN, Hisdal J, Humerfelt S, Steine K.

Eur Respir J. 2013 May;41(5):1031-41. doi: 10.1183/09031936.00085612. Epub 2012 Aug 16.

14.

The association between lung function and fatal stroke in a community followed for 4 decades.

Gulsvik AK, Gulsvik A, Skovlund E, Thelle DS, Mowé M, Humerfelt S, Wyller TB.

J Epidemiol Community Health. 2012 Nov;66(11):1030-6. doi: 10.1136/jech-2011-200312. Epub 2012 Apr 7.

PMID:
22493479
15.

[A 40ish man with weight loss and scrotum edema].

Nøkleby K, Berge V, Stiris M, Tufteland KF, Humerfelt S.

Tidsskr Nor Laegeforen. 2010 Oct 21;130(20):2026-8. doi: 10.4045/tidsskr.09.0486. Norwegian. No abstract available.

16.

Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates.

Gulsvik A, Humerfelt S, Bakke PS, Omenaas ER, Lehmann S.

Clin Respir J. 2008 Oct;2 Suppl 1:10-25. doi: 10.1111/j.1752-699X.2008.00080.x.

PMID:
20298346
17.

Increased awareness of COPD in the Norwegian population.

Gulsvik A, Myrseth SE, Henrichsen SH, Humerfelt S, Omenaas E.

Clin Respir J. 2007 Dec;1(2):118-9. doi: 10.1111/j.1752-699X.2007.00026.x. No abstract available.

PMID:
20298291
18.

Rheumatic mitral valve stenosis mimicking advanced lung cancer.

von Lueder T, Steine K, Nerdrum T, Steen T, Bay D, Humerfelt S, Atar D.

Heart Vessels. 2007 Sep;22(5):345-8. Epub 2007 Sep 20.

PMID:
17879027
19.

Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta2-agonist.

Lehmann S, Bakke PS, Eide GE, Humerfelt S, Gulsvik A.

Pulm Pharmacol Ther. 2006;19(4):272-80. Epub 2005 Sep 19.

PMID:
16169762
20.

[Clinical pharmacist improves the use of drugs in hospital].

Pretsch P, Hertzenberg SW, Humerfelt S.

Tidsskr Nor Laegeforen. 2004 Aug 12;124(15):1923-5. Norwegian.

21.

Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway.

Gulsvik A, Tosteson T, Bakke P, Humerfelt S, Weiss ST, Speizer FE.

Clin Physiol. 2001 Nov;21(6):648-60.

PMID:
11722472
22.

Standardized submaximal exercise testing in never smokers: a normative study.

Gulsvik A, Beckett LA, Bakke P, Humerfelt S, Omenaas E, Speizer FE.

Clin Physiol. 2001 Sep;21(5):629-36.

PMID:
11576165
24.

Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) variability in asymptomatic never-smoking men.

Humerfelt S, Eide GE, Kvåle G, Gulsvik A.

Clin Physiol. 1998 Jul;18(4):387-96.

PMID:
9715766
25.
26.

[Pulmonary health among farmers].

Bakke PS, Humerfelt S.

Tidsskr Nor Laegeforen. 1995 Aug 30;115(20):2519-20. Norwegian. No abstract available.

PMID:
7676411
27.
28.

Decline in FEV1 and airflow limitation related to occupational exposures in men of an urban community.

Humerfelt S, Gulsvik A, Skjaerven R, Nilssen S, Kvåle G, Sulheim O, Ramm E, Eilertsen E, Humerfelt SB.

Eur Respir J. 1993 Sep;6(8):1095-103.

PMID:
8224123
29.

[Acupuncture, quality control and ethics].

Broch OJ, Gogstad A, Humerfelt S.

Tidsskr Nor Laegeforen. 1993 May 30;113(14):1758. Norwegian. No abstract available.

PMID:
8322316
30.

Single breath transfer factor for carbon monoxide in an asymptomatic population of never smokers.

Gulsvik A, Bakke P, Humerfelt S, Omenaas E, Tosteson T, Weiss ST, Speizer FE.

Thorax. 1992 Mar;47(3):167-73.

31.

[Simple spirometry and peak flow measurements].

Humerfelt S, Aasen TB, Gulsvik A.

Tidsskr Nor Laegeforen. 1990 Sep 30;110(23):3019-20. Norwegian. No abstract available.

PMID:
2237856
32.

[Fatal cocaine poisoning].

Humerfelt S, Larsen EW, Osnes M, Bredesen JE.

Tidsskr Nor Laegeforen. 1987 Jun 30;107(19-21):1657-8. Norwegian. No abstract available.

PMID:
3629572
33.

Hyperdontia in children below four years of age: a radiographic study.

Humerfelt D, Hurlen B, Humerfelt S.

ASDC J Dent Child. 1985 Mar-Apr;52(2):121-4.

PMID:
3857242
34.

The diastolic end-point.

Humerfelt S.

J R Coll Gen Pract Occas Pap. 1980 Jul;(12):2-3. No abstract available.

35.

The organisation of treatment of hypertension; the role of the general practitioner.

Humerfelt S.

Acta Med Scand Suppl. 1979;626:73-4. No abstract available.

PMID:
285601
36.

[The external services of the hospital].

Humerfelt S.

Tidsskr Nor Laegeforen. 1976 Jul 10;96(19-21):1083-7. Norwegian. No abstract available.

PMID:
184561
37.

[Clinical evaluation of new drugs in general practice].

Humerfelt S.

Tidsskr Nor Laegeforen. 1974 Feb 10;94(4):246-7. Norwegian. No abstract available.

PMID:
4821970
38.

[Use of the laboratory in general practice].

Humerfelt S.

Tidsskr Nor Laegeforen. 1973 Aug 10;93(21):1530-1. Norwegian. No abstract available.

PMID:
4766374
39.

The observer variation in the measurement of arterial blood pressure.

Eilertsen E, Humerfelt S.

Acta Med Scand. 1968 Sep;184(3):145-57. No abstract available.

PMID:
5703970
40.

[Blood pressure distribution in a population group. Bergen 1963-1964. Epidemiological aspects].

Humerfelt S.

Tidsskr Nor Laegeforen. 1968 Jul 15;88(14):1406-10. Norwegian. No abstract available.

PMID:
5699217
41.

The blood pressure in a representative population sample.

Eilertsen E, Humerfelt S.

Acta Med Scand. 1968 Apr;183(4):293-305. No abstract available.

PMID:
5666619
42.

[Progressive patient care. Medical aspects].

Humerfelt SB.

Tidsskr Nor Laegeforen. 1968 Jan 15;88(2):60-5. Norwegian. No abstract available.

PMID:
5663308
43.

[The vicious circle in the development of irreversible shock].

Humerfelt SB.

Tidsskr Nor Laegeforen. 1966 May 1;86(9):671-4. Norwegian. No abstract available.

PMID:
5916255
44.

A cardiovascular survey of British postal workers.

Reid DD, Holland WW, Humerfelt S, Rose G.

Lancet. 1966 Mar 19;1(7438):614-8. No abstract available.

PMID:
4159990
45.

MEASUREMENT OF BLOOD-PRESSURE: COMPARISON OF INTRA-ARTERIAL AND CUFF VALUES.

HOLLAND WW, HUMERFELT S.

Br Med J. 1964 Nov 14;2(5419):1241-3. No abstract available.

46.

EFFECTS OF GUANETHIDINE ON RENAL FUNCTION.

ABRAHAMSEN AM, HUMERFELT S, SIGSTAD H.

Acta Med Scand. 1964 Jul;176:59-63. No abstract available.

PMID:
14194191
47.

Combined guanethidine and hydrochlorothiazide therapy in hypertension.

ABRAHAMSEN AM, HUMERFELT S, SIGSTAD H.

Acta Med Scand. 1963 Feb;173:155-64. No abstract available.

PMID:
14010743
48.
49.

The use of dye dilution curves in congential heart diseases.

HUMERFELT S, HAARSTAD J, MYHRE J, BROCH OJ.

Acta Med Scand. 1961 Apr;169:437-49. No abstract available.

PMID:
13716801
50.

Patent ductus arteriosus Botalli in an octogenarian followed for fifty years.

BOE J, HUMERFELT S.

Acta Med Scand. 1960 May 20;167:73-5. No abstract available.

PMID:
13801945

Supplemental Content

Loading ...
Support Center